Status:
COMPLETED
Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
Lead Sponsor:
Universidade Federal de Goias
Conditions:
Diabetic Macular Edema
Eligibility:
All Genders
40-90 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare a single intravitreal injection of 4.0 mg of triamcinolone acetonide and 1.25 mg of bevacizumab for the treatment of diabetic macular edema.
Detailed Description
Comparison a single intravitreal injection of 4.0 mg of triamcinolone acetonide and 1.25 mg of bevacizumab regarding the ability of central macular thickness reduction. Secondary objectives are analys...
Eligibility Criteria
Inclusion
- Diabetic macular edema with central foveal measurement over 300 micrometers
Exclusion
- Glaucoma
- Vitreoretinal surgery
- Cataract Surgery less than 3 months prior inclusion
- Unilateral cataract surgery
- Uncontrolled Glycosylated Hemoglobin
- Previous Intraocular Injection
- Systemic Corticosteroids less than 1 month prior inclusion
- Macular ischemia at Fluorescein Angiography
- Cataract precluding fundus examination
- Active Proliferative Diabetic Retinopathy
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00874744
Start Date
March 1 2008
End Date
October 1 2008
Last Update
April 2 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.